Citadel Advisors’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-75,551
| Closed | -$2.6M | – | 5917 |
|
|
2020
Q3 | $2.6M | Sell |
75,551
-176,464
| -70% | -$6.08M | ﹤0.01% | 2034 |
|
|
2020
Q2 | $4.21M | Sell |
252,015
-9,486
| -4% | -$159K | ﹤0.01% | 1624 |
|
|
2020
Q1 | $3.77M | Buy |
261,501
+133,108
| +104% | +$1.92M | ﹤0.01% | 1667 |
|
|
2019
Q4 | $4.3M | Sell |
128,393
-107,178
| -45% | -$3.59M | ﹤0.01% | 1737 |
|
|
2019
Q3 | $4.93M | Buy |
235,571
+15,955
| +7% | +$334K | ﹤0.01% | 1675 |
|
|
2019
Q2 | $4.57M | Buy |
219,616
+101,081
| +85% | +$2.1M | ﹤0.01% | 1726 |
|
|
2019
Q1 | $2.65M | Sell |
118,535
-55,144
| -32% | -$1.23M | ﹤0.01% | 2080 |
|
|
2018
Q4 | $4.15M | Buy |
173,679
+133,564
| +333% | +$3.19M | ﹤0.01% | 1618 |
|
|
2018
Q3 | $1.09M | Buy |
40,115
+624
| +2% | +$17K | ﹤0.01% | 2649 |
|
|
2018
Q2 | $1.06M | Buy |
39,491
+29,627
| +300% | +$797K | ﹤0.01% | 2609 |
|
|
2018
Q1 | $314K | Sell |
9,864
-13,269
| -57% | -$422K | ﹤0.01% | 3228 |
|
|
2017
Q4 | $875K | Sell |
23,133
-536,508
| -96% | -$20.3M | ﹤0.01% | 2467 |
|
|
2017
Q3 | $13.9M | Buy |
559,641
+542,111
| +3,092% | +$13.4M | 0.01% | 798 |
|
|
2017
Q2 | $360K | Buy |
+17,530
| New | +$360K | ﹤0.01% | 2785 |
|
|
2017
Q1 | – | Sell |
-34,868
| Closed | -$713K | – | 4364 |
|
|
2016
Q4 | $713K | Buy |
34,868
+17,924
| +106% | +$367K | ﹤0.01% | 2215 |
|
|
2016
Q3 | $254K | Sell |
16,944
-279
| -2% | -$4.18K | ﹤0.01% | 2913 |
|
|
2016
Q2 | $186K | Buy |
+17,223
| New | +$186K | ﹤0.01% | 2834 |
|